Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome

Eirini I Rigopoulou1, Kalliopi Zachou, Nikolaos K Gatselis

  • 1Eirini I Rigopoulou, Kalliopi Zachou, Nikolaos K Gatselis, Georgia Papadamou, Department of Medicine and Research Laboratory of Internal Medicine, Medical School, University of Thessaly, 41110 Larissa, Greece.

Insights

Diagnosing primary biliary cirrhosis (PBC) in patients with hepatitis B virus (HBV) or hepatitis C virus (HCV) is challenging and often delayed. Cholestasis in these patients warrants further investigation for concurrent PBC.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Immunology

Background:

  • Primary biliary cirrhosis (PBC) is a chronic liver disease.
  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) are common viral infections affecting the liver.
  • Concurrent infections of viral hepatitis and PBC present unique diagnostic and management challenges.

Purpose of the Study:

  • To characterize patients with concurrent primary biliary cirrhosis (PBC) and hepatitis B virus (HBV) or hepatitis C virus (HCV) infections.
  • To evaluate the management and outcomes of these patients.
  • To highlight diagnostic difficulties and delays in concurrent PBC and viral hepatitis.

Main Methods:

  • Retrospective evaluation of medical records from January 2001 to September 2009.
  • Identification of patients with concurrent HBV or HCV and PBC based on established diagnostic criteria.
  • Analysis of patient demographics, clinical presentation, diagnosis timing, and disease progression.

Main Results:

  • Hepatitis B virus (HBV) or hepatitis C virus (HCV) diagnosis typically preceded primary biliary cirrhosis (PBC) diagnosis by many years.
  • Patients with PBC and HBV were younger at PBC diagnosis than those with PBC and HCV.
  • A higher proportion of patients with concurrent PBC and HCV had cirrhosis at initial assessment compared to those with PBC and HBV.

Conclusions:

  • Diagnosis of primary biliary cirrhosis (PBC) in patients with hepatitis B virus (HBV) or hepatitis C virus (HCV) is often delayed.
  • Physicians should consider PBC in patients presenting with cholestasis, even with known viral hepatitis.
  • Early detection and management are crucial for improving outcomes in these complex cases.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
32
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
53
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
275
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
908